Premium
Temporal dynamics of serum let‐7g expression mirror the decline of residual beta‐cell function in longitudinal observation of children with type 1 diabetes
Author(s) -
Małachowska Beata,
Wyka Krystyna,
Nowicka Zuzanna,
Bartłomiejczyk Marcin A.,
Młynarski Wojciech,
Fendler Wojciech
Publication year - 2018
Publication title -
pediatric diabetes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.678
H-Index - 75
eISSN - 1399-5448
pISSN - 1399-543X
DOI - 10.1111/pedi.12783
Subject(s) - type 1 diabetes , medicine , autoantibody , diabetes mellitus , antibody , islet , autoimmunity , insulin , endocrinology , biomarker , beta cell , microrna , real time polymerase chain reaction , immunology , biology , gene , genetics
Background/Objective In type 1 diabetes mellitus (T1DM), the introduction of insulin is typically followed by a brief remission period, with subsequent gradual decline in beta‐cell function. Several studies described altered profile of circulating miRNAs (microRNAs) in T1DM patients and proposed them as biomarkers of associated pathologic processes. Hypothesis Serum miRNA expression profile reflects residual beta‐cell function and autoimmunity in T1DM. Subjects The profiling group included patients with: GCK‐MODY (N = 13), T1DM (N = 9), and 10 healthy controls. The longitudinal group included 34 patients with samples collected at diagnosis of T1DM and first, third, and fourth to eighth year since diagnosis. Methods We reanalyzed data from the profiling group for miRNAs differentially expressed between patients with T1DM, other types of diabetes and controls. Afterward, we shortlisted miRNAs on the basis of this reanalysis and literature review and quantified their expression with quantitative polymerase chain reaction. Additionally, we measured the levels of anti‐islet antibodies (islet cell antibodies, glutamic acid decarboxylase antibodies, IA2 antibodies, and ZnT8A) and C‐peptide concentrations across the four timepoints in the longitudinal group. Results miR‐24 and let‐7g serum expression differed significantly between GCK‐MODY, controls, and HbA1c‐matched T1DM patients; P < 0.05, false discovery rate < 0.05. Autoantibodies levels showed decreasing linear trend in repeated timepoints (all P < 0.0001). C‐peptide concentration peaked during the first year after diagnosis, corresponding to remission phase, and declined in consecutive measurements. This dynamic was evidenced for let‐7g expression levels ( P = 0.0058). Conclusions The pattern of let‐7g expression change during the course of diabetes mirrors that of C‐peptide levels, hinting at this microRNA's association with the residual mass of the beta cells in patients with T1DM.